PL3398598T3 - Pochodne sulfonoamidowe oraz sposoby ich wytwarzania i zastosowanie - Google Patents

Pochodne sulfonoamidowe oraz sposoby ich wytwarzania i zastosowanie

Info

Publication number
PL3398598T3
PL3398598T3 PL16881237.8T PL16881237T PL3398598T3 PL 3398598 T3 PL3398598 T3 PL 3398598T3 PL 16881237 T PL16881237 T PL 16881237T PL 3398598 T3 PL3398598 T3 PL 3398598T3
Authority
PL
Poland
Prior art keywords
preparation
sulfonamide derivative
sulfonamide
derivative
Prior art date
Application number
PL16881237.8T
Other languages
English (en)
Inventor
Jin Li
Xueming LI
Dengfeng DOU
Jinqiao Wan
Wei Zhang
Jingming Li
Yan Lan
Linli LI
Original Assignee
Hitgen Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hitgen Inc. filed Critical Hitgen Inc.
Publication of PL3398598T3 publication Critical patent/PL3398598T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96—Sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
PL16881237.8T 2015-12-31 2016-12-29 Pochodne sulfonoamidowe oraz sposoby ich wytwarzania i zastosowanie PL3398598T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201511029249 2015-12-31
PCT/CN2016/112896 WO2017114448A1 (zh) 2015-12-31 2016-12-29 磺酰胺衍生物及其制备方法与应用

Publications (1)

Publication Number Publication Date
PL3398598T3 true PL3398598T3 (pl) 2022-08-22

Family

ID=59225913

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16881237.8T PL3398598T3 (pl) 2015-12-31 2016-12-29 Pochodne sulfonoamidowe oraz sposoby ich wytwarzania i zastosowanie

Country Status (12)

Country Link
US (1) US11149008B2 (pl)
EP (1) EP3398598B1 (pl)
JP (1) JP6804540B2 (pl)
KR (1) KR102264012B1 (pl)
CN (1) CN106928198B (pl)
AU (1) AU2016382372B2 (pl)
CA (1) CA3010326C (pl)
DK (1) DK3398598T3 (pl)
ES (1) ES2920888T3 (pl)
PL (1) PL3398598T3 (pl)
PT (1) PT3398598T (pl)
WO (1) WO2017114448A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2734713T3 (es) 2015-07-06 2019-12-11 Gilead Sciences Inc Moduladores Cot y métodos de utilización de los mismos
WO2019080882A1 (zh) * 2017-10-25 2019-05-02 成都先导药物开发有限公司 Hdac抑制剂及其制备方法和用途
CN108299255B (zh) * 2018-02-11 2020-05-19 山东大学 组蛋白去乙酰化酶8选择性抑制剂及其制备方法和应用
TWI915558B (zh) 2019-06-14 2026-02-21 美商基利科學股份有限公司 Cot 調節劑及其使用方法
CA3175541A1 (en) 2020-03-30 2021-10-07 Gilead Sciences, Inc. Solid forms of (s)-6-(((1-(bicyclo[1.1.1]pentan-1-yl)-1h-1,2,3-triazol-4-yl)2-methyl-1-oxo-1,2- dihydroisoquinolin-5-yl)methyl)))amino)8-chloro-(neopentylamino)quinoline-3-carb onitrile a cot inhibitor compound
EP4126862B1 (en) 2020-04-02 2025-05-21 Gilead Sciences, Inc. Process for preparing a cot inhibitor compound
US20250304549A1 (en) * 2022-05-20 2025-10-02 Sichuan Huiyu Pharmaceutical Co., Ltd. Hydroxyamide derivative and use thereof
CN116803983B (zh) * 2022-05-26 2026-07-24 杭州师范大学 一种组蛋白去乙酰化酶和热休克蛋白110KDa双靶点抑制剂及应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2476583C (en) * 2002-03-13 2011-07-05 Kristof Van Emelen Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
AU2003252355A1 (en) * 2002-08-01 2004-02-23 Mochida Pharmaceutical Co., Ltd. Novel crystalline tryptase and utilization thereof
US7345043B2 (en) * 2004-04-01 2008-03-18 Miikana Therapeutics Inhibitors of histone deacetylase
ITFI20050041A1 (it) * 2005-03-15 2006-09-16 Menarini Internat Operations Luxembourg Sa Idrossammati come inibitori dell'istone deacelitasi, loro preparazione e formulazioni farmaceutiche che li contengono
AU2008345225A1 (en) * 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
MX2011000512A (es) * 2008-07-14 2011-02-24 Novartis Ag Inhibidores selectivos de mmp-12 y mmp-13 basados en acido hidroxamico.
US9914717B2 (en) * 2012-12-20 2018-03-13 The Broad Institute, Inc. Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors
CN105732459B (zh) * 2014-12-29 2019-05-31 成都先导药物开发有限公司 吡咯酰胺类化合物及其制备方法与用途

Also Published As

Publication number Publication date
CA3010326C (en) 2020-07-14
ES2920888T3 (es) 2022-08-11
AU2016382372A1 (en) 2018-07-19
US11149008B2 (en) 2021-10-19
DK3398598T3 (da) 2022-07-11
KR102264012B1 (ko) 2021-06-10
EP3398598A4 (en) 2018-11-07
AU2016382372B2 (en) 2019-09-19
PT3398598T (pt) 2022-07-12
WO2017114448A1 (zh) 2017-07-06
CN106928198B (zh) 2020-07-28
JP2019501919A (ja) 2019-01-24
JP6804540B2 (ja) 2020-12-23
EP3398598A1 (en) 2018-11-07
CN106928198A (zh) 2017-07-07
EP3398598B1 (en) 2022-04-06
CA3010326A1 (en) 2017-07-06
US20190031612A1 (en) 2019-01-31
KR20180086258A (ko) 2018-07-30

Similar Documents

Publication Publication Date Title
ZA201804070B (en) Eif4-a-inhibiting compounds and methods related thereto
ZA201805805B (en) Formulations and methods
GB2546350B (en) Compositions and methods
ZA201702161B (en) Insecticidal proteins and methods for their use
ZA201605154B (en) Insecticidal proteins and methods for their use
EP3159424A4 (en) Rebar and preparation method thereof
ZA201608046B (en) Pesticidal compositions and related methods
PL3205650T3 (pl) Inhibitor EGFR i jego otrzymywanie i zastosowanie
GB201718876D0 (en) Antithrombin-heparin compositions and methods
GB201519128D0 (en) Solid forms and methods of preparing the same
IL256381A (en) Cryoprecipitate compositions and methods of preparation thereof
GB201603311D0 (en) New uses and methods
PT3398598T (pt) Derivado de sulfonamida e método de preparação e utilização do mesmo
SG11201704473WA (en) New methods and uses
EP3093296A4 (en) Fuc3s4s substituted oligoglycosaminoglycan and preparation method thereof
GB201416293D0 (en) Methods and preparations
ZA201704743B (en) Mangiferin-6-o-berberine salt and preparation method and use thereof
GB201612858D0 (en) New uses and methods
EP3253408A4 (en) Anti-pre-bcr antagonists and methods
ZA201703398B (en) Pharmaceutical composition and methods
EP3130340A4 (en) Isoacteoside derivative and preparation method and use thereof
GB2548839B (en) New uses and methods
IL253174A0 (en) Nanoparticles and methods for their preparation
EP3381921A4 (en) GINKGOLIDE B DERIVATIVE AND METHOD OF PREPARING THEREOF AND USE THEREOF
HUE049249T2 (hu) Alfa-azaril-aldehid észter, elõállítási eljárása és alkalmazása